Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
01/07/1998 | EP0656897B1 Quinuclidine derivatives as squalene synthase inhibitors |
01/07/1998 | EP0656888B1 Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
01/07/1998 | EP0613458B1 Acyclic ethylenediamine derivatives as substance p receptor antagonists |
01/07/1998 | EP0592490B1 Amino acid derivative anticonvulsant |
01/07/1998 | EP0584062B1 Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins |
01/07/1998 | EP0565396B1 1-[2-(arylsulfonylamino)-1-oxoethyl]piperidine derivatives, their preparation and use in therapy |
01/07/1998 | EP0542795B1 Tnf inhibitors |
01/07/1998 | EP0539442B1 Enzyme inactivators |
01/07/1998 | EP0482071B1 New antiviral agents |
01/07/1998 | EP0427741B1 Subsaturated transdermal delivery device |
01/07/1998 | CN1169731A Tachykinin antagonists |
01/07/1998 | CN1169730A Aromatic heterocyclic derivatives as enzyme inhibitors |
01/07/1998 | CN1169727A Erythromycin A 9-0-oxime derivatives endowed with antibiotic activity |
01/07/1998 | CN1169726A 6-aryl pyrido (2,3-d) pyrimidines and naphthyridines for inhibiting protein tyrosine kinase medicated cellular proliferation |
01/07/1998 | CN1169724A Process for preparing phenyl propionitaxiene-13a ester trihydrate |
01/07/1998 | CN1169722A 5-lipoxygenase inhibitors |
01/07/1998 | CN1169679A Method of inhibiting discase associated with bradykinin |
01/07/1998 | CN1169678A Method of inhibiting primary endometrial hyperplasia |
01/07/1998 | CN1169677A Use of pramipexole as nerveprotective agent |
01/07/1998 | CN1169676A Oral pharmaceutical formulation containing magnesium salt of omeprazole |
01/07/1998 | CN1169659A Feed for farmed fish, method to provide fish of high quality and use of additional components to prepare said feed |
01/07/1998 | CN1169657A Skin-care composition |
01/07/1998 | CN1169435A Compound-silver glycyrrhetate preparation method and use thereof |
01/07/1998 | CN1169433A Carbohydrate derivatives |
01/07/1998 | CN1169431A Novel cephalosporin derivatives and processes for preparation thereof |
01/07/1998 | CN1169430A Optical active 2, 3-dihydro-imidazole and £1, 2-c| quinazoline derivative, preparation method and use thereof |
01/07/1998 | CN1169429A Sulfamine-substituted benzodihydopyran, preparation method, use as medicine or diagnostic reagent and medicine containing same |
01/07/1998 | CN1169426A Novel pyridajinone derivatives |
01/07/1998 | CN1169425A Fluorinated vitamin D3 analogs |
01/07/1998 | CN1169312A Junbisha privates-cleaning effervescence preparation and preparation technology thereof |
01/07/1998 | CN1169303A Medical use of cumarin in the root of purple-flowered peucedanum of traditional Chinese herb, and extraction method thereof |
01/07/1998 | CN1169285A Medicament for preventive and/or therapeutic treatment of hyperphosphatemia |
01/07/1998 | CN1169284A Sodium alginate diester for preventing and curing thrombocytopenia and leukopenia |
01/07/1998 | CN1036920C Heterocycle-containing carbonic acid derivatives |
01/07/1998 | CN1036918C Novel benzopyran derivatives and activating agent containing same |
01/06/1998 | US5705890 Platelet aggregation inhibitor, antithrombotic |
01/06/1998 | US5705703 Enzyme inhibitors of transferases |
01/06/1998 | US5705687 Neurotropic drug and method for preparation of same |
01/06/1998 | US5705662 Hypotensive agents |
01/06/1998 | US5705658 Azido containing tetrahydro furan compounds |
01/06/1998 | US5705654 Antiandrogens |
01/06/1998 | US5705647 Intermediates for making HIV-protease inhibitors |
01/06/1998 | US5705645 Hereroaryl derivatives of monocyclic beta-lactam antibiotics |
01/06/1998 | US5705625 Genetic engineering; medical diagnosis |
01/06/1998 | US5705531 Congestive heart failure and hypertension treatment |
01/06/1998 | US5705530 Side effect reduction; glaucoma treatment |
01/06/1998 | US5705529 N-benzoyl amino acid derivatives pharmaceutical compositions containing them and process for preparing same |
01/06/1998 | US5705528 Farnesyl derivatives and pharmaceutical compositions containing them |
01/06/1998 | US5705527 Amino acid derivatives |
01/06/1998 | US5705526 Hypercholesterolemia therapeutic agent |
01/06/1998 | US5705525 Thiophene compounds |
01/06/1998 | US5705523 Thromboxane a2 synthetase inhibitors |
01/06/1998 | US5705522 Compounds having anti-inflammatory and anti-viral activity, compositions of these, alone and in combination with reverse transcriptase inhibitors |
01/06/1998 | US5705521 Use of allosteric hemoglobin modifiers in combination with radiation therapy to treat carcinogenic tumors |
01/06/1998 | US5705520 Medicaments |
01/06/1998 | US5705519 Method for treating 5-HT2B receptor related conditions |
01/06/1998 | US5705517 Benzimidazole derivatives and use thereof |
01/06/1998 | US5705515 Having reduced side effects |
01/06/1998 | US5705514 Signal transduction inhibitor compounds |
01/06/1998 | US5705513 Fungicides for the control of take-all disease of plants |
01/06/1998 | US5705511 Fused pyrrolocarbazoles |
01/06/1998 | US5705510 Use of cabergoline and related ergoline derivatives for controlling intraocular pressure |
01/06/1998 | US5705509 Tricyclic heterocyclic compounds as 5-HT4 receptor antagonists |
01/06/1998 | US5705508 Forming taxol derivatives |
01/06/1998 | US5705507 Aplha-substituted-3-benzyl-benzofurans |
01/06/1998 | US5705506 Pharmaceutical compositions of alkylsulphonamides 5HT1 agonists for rectal administration |
01/06/1998 | US5705505 3-piperidinyl-alkyl-2h-isoquinolin-1-(thi)one derivatives; neurokinin antagonists |
01/06/1998 | US5705504 Platelet activating factor |
01/06/1998 | US5705502 Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof |
01/06/1998 | US5705501 Certain substituted 1-aryl-3-morpholinopropanones to treat Alzheimer's Disease |
01/06/1998 | US5705500 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
01/06/1998 | US5705499 Viricides |
01/06/1998 | US5705498 Piperidine derivatives as 5-HT4 receptor antagonists |
01/06/1998 | US5705497 Inotropic, antiarrhythmia agents |
01/06/1998 | US5705496 Crystalline benzathine salt of cefonicid and its preparation |
01/06/1998 | US5705494 Anti-estrogenic activity of IIβ-substituted-19-NOR Steroids |
01/06/1998 | US5705492 3'-O-aminoacyl ARA uridines, method of making, and antiviral activity |
01/06/1998 | US5705490 Treatment of herpes or cytomegalovirus with benzimidazole deriatives |
01/06/1998 | US5705489 Having antithrombotic activity |
01/06/1998 | US5705485 Gel formulations containing growth factors |
01/06/1998 | US5705401 Method of assaying for alzheimer's disease |
01/06/1998 | US5705389 Oligonucleotides that inhibit production of α-tumor necrosis factor |
01/06/1998 | US5705388 CETP Ribozymes |
01/06/1998 | US5705335 Design of drugs involving receptor-ligand-DNA interactions |
01/06/1998 | US5705195 Drug delivery into blood for cardiovascular disorders |
01/06/1998 | US5705194 Bioavailability, nose, mouth, eyes |
01/06/1998 | US5705192 Fluidized beds and spraying then removal of solvent and forming tablets |
01/06/1998 | US5705190 Comprising water soluble alginate, complex salt of alginic acid, and organic carboxylic acid; with clarithromycin |
01/06/1998 | US5705188 Lipid mixture, antitumor agents |
01/06/1998 | US5705186 Pharmaceutical composition for the systemic transdermal administration having the active substance morphine-6-glucuronide |
01/06/1998 | US5705185 Prevention degradation of estradiol during permeation |
01/06/1998 | US5705184 Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses |
01/06/1998 | US5705180 Therapeutic agent for the treatment of melanomas |
01/06/1998 | US5705178 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
01/06/1998 | US5705177 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
01/06/1998 | US5705169 Ketotricyclo .5.2.1.0! decane derivatives |
01/06/1998 | US5705168 Lactic acid for skin disorders |
01/06/1998 | US5705167 Treatment of dermatological, rheumatic, respiratory, cardiovascular, bone and ophthalmological disorders |
01/06/1998 | US5705156 Pseudomonas exotoxins binding to cells |
01/06/1998 | US5705144 Skin lightening composition and radiation resistance |